|
[1]
|
Carvedilol- loaded Transdermal Ethosomal gel: Characterization, ex vivo/in vivo Evaluation
Research Journal of Pharmacy and Technology,
2022
DOI:10.52711/0974-360X.2022.00673
|
|
|
|
|
[2]
|
In Vitro Permeation Studies on Carvedilol Containing Dissolving Microarray Patches Quantified Using a Rapid and Simple HPLC-UV Analytical Method
AAPS PharmSciTech,
2022
DOI:10.1208/s12249-022-02422-6
|
|
|
|
|
[3]
|
Low‐volume LC–MS/MS method for the pharmacokinetic investigation of carvedilol, enalapril and their metabolites in whole blood and plasma: Application to a paediatric clinical trial
Drug Testing and Analysis,
2021
DOI:10.1002/dta.2949
|
|
|
|
|
[4]
|
Development and optimization of ocular in situ gels loaded with ciprofloxacin cubic liquid crystalline nanoparticles
Journal of Drug Delivery Science and Technology,
2020
DOI:10.1016/j.jddst.2020.101710
|
|
|
|
|
[5]
|
Chitosan-TPP Nanoparticles Stabilized by Poloxamer for Controlling the Release and Enhancing the Bioavailability of Doxazosin Mesylate: In Vitro, and In Vivo Evaluation
Drug Development and Industrial Pharmacy,
2019
DOI:10.1080/03639045.2019.1597105
|
|
|
|
|
[6]
|
Development and validation of UPLC method for simultaneous quantification of carvedilol and ivabradine in the presence of degradation products using DoE concept
Journal of Liquid Chromatography & Related Technologies,
2018
DOI:10.1080/10826076.2018.1427595
|
|
|
|
|
[7]
|
Quality by design approach to screen the formulation and process variables influencing the characteristics of carvedilol solid lipid nanoparticles
Journal of Drug Delivery Science and Technology,
2018
DOI:10.1016/j.jddst.2018.03.010
|
|
|
|
|
[8]
|
Integration of in vitro biorelevant dissolution and in silico PBPK model of carvedilol to predict bioequivalence of oral drug products
European Journal of Pharmaceutical Sciences,
2018
DOI:10.1016/j.ejps.2018.03.032
|
|
|
|
|
[9]
|
Optimization of carvedilol solid lipid nanoparticles: An approach to control the release and enhance the oral bioavailability on rabbits
PLOS ONE,
2018
DOI:10.1371/journal.pone.0203405
|
|
|
|
|
[10]
|
Development, Optimization, and Evaluation of Carvedilol-Loaded Solid Lipid Nanoparticles for Intranasal Drug Delivery
AAPS PharmSciTech,
2016
DOI:10.1208/s12249-015-0440-8
|
|
|
|
|
[11]
|
Nanotransfersomes of carvedilol for intranasal delivery: formulation, characterization andin vivoevaluation
Drug Delivery,
2015
DOI:10.3109/10717544.2015.1013587
|
|
|
|